Splenic T Zone Development Is B Cell Dependent by Ngo, Vu N. et al.
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2001/12/1649/12 $5.00
Volume 194, Number 11, December 3, 2001 1649–1660
http://www.jem.org/cgi/content/full/194/11/1649
 
1649
 
Splenic T Zone Development Is B Cell Dependent
 
Vu N. Ngo,
 
1
 
 Richard J. Cornall,
 
2
 
 and Jason G. Cyster
 
1
 
1
 
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of 
California San Francisco, San Francisco, CA 94143
 
2
 
Nufﬁeld Department of Medicine, Oxford University, John Radcliffe Hospital, Headington, Oxford 
OX3 9DU, United Kingdom
 
Abstract
 
The factors regulating growth and patterning of the spleen are poorly defined. We demonstrate
here that spleens from B cell–deficient mice have 10-fold reduced expression of the T zone
chemokine, CCL21, a threefold reduction in T cell and dendritic cell (DC) numbers, and re-
duced expression of the T zone stromal marker, gp38. Using cell transfer and receptor blocking
approaches, we provide evidence that B cells play a critical role in the early postnatal develop-
ment of the splenic T zone. This process involves B cell expression of lymphotoxin (LT)
 
 
 
1
 
 
 
2,
a cytokine that is required for expression of CCL21 and gp38. Introduction of a B cell specific
LT
 
 
 
 transgene on to the LT
 
 
 
-deficient background restored splenic CCL21 and gp38 expres-
sion, DC numbers, and T zone size. This work also demonstrates that the role of B cells in T
zone development is distinct from the effect of B cells on splenic T cell numbers, which does
not require LT
 
 
 
1
 
 
 
2. Therefore, B cells influence spleen T zone development by providing: (a)
signals that promote T cell accumulation, and: (b) signals, including LT
 
 
 
1
 
 
 
2, that promote
stromal cell development and DC accumulation. Defects in these parameters may contribute to
the immune defects associated with B cell deficiency in mice and humans.
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Introduction
 
The spleen participates in immune responses against many
types of pathogens and it is also involved in autoimmune
diseases and lymphoid malignancies (1). Within the spleen,
lymphocytes are organized as sheathes around arterioles,
with the T zone located centrally (also called the periarteri-
olar lymphoid sheath or PALS) and the B cells distributed
around the T zone in tightly packed follicles. The spleen
contains an additional population of B cells in a compart-
ment that surrounds the follicles, known as the marginal
zone (2). Antigen-presenting dendritic cells (DCs)
 
*
 
 are
prevalent in marginal zones, T cell zones, and in the bridg-
ing channels between these two compartments (3). The T
zones, follicles, and marginal zones of the spleen are com-
monly referred to as the white pulp cords and they account
for approximately half of the splenic tissue (1). The remain-
der of the spleen, termed red pulp, contains large numbers
of macrophages, vascular cells, and transiting blood cells.
This compartment functions in red cell and immune com-
plex clearance and leukocyte exit.
Current understanding of the factors that cause growth
and patterning of lymphoid organs is limited. Within the B
and T cell areas there are specialized chemokine-producing
stromal cells, believed to be of mesenchymal origin, that
help organize the tissue (4, 5). Follicular stromal cells pro-
duce CXCL13 (BLC), a ligand for CXCR5, and both
CXCR5 and CXCL13 are necessary for formation of B
cell follicles (6, 7). A subset of follicular stromal cells,
known as follicular DCs (FDCs), express complement and
Fc receptors and are able to trap immune complexes for
presentation to B cells. Normal expression of CXCL13 and
development of FDCs is dependent on signals provided by
B cells (8–10). Recent studies indicated that maturation of
FDCs depends on a positive feedback loop between
CXCL13 and the cytokine lymphotoxin (LT)
 
 
 
1
 
 
 
2, where
CXCL13 mediates recruitment of CXCR5-expressing B
cells and induces them to express LT
 
 
 
1
 
 
 
2 (7). LT
 
 
 
1
 
 
 
2
causes growth and maturation of the follicular stromal cells,
leading to increased expression of CXCL13 and upregula-
tion of FDC markers (7). Stromal cells within T cell areas
produce the CC chemokines, CCL21 (SLC) and CCL19
(ELC) (11). In mice lacking lymphoid CCL21 and CCL19
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(11, 12), or in animals deficient in the common CCL21
and CCL19 receptor, CCR7 (13), there is a severe paucity
of T cells and DCs within splenic T zones, while follicles
continue to develop. Expression of these chemokines is
also dependent on LT
 
 
 
1
 
 
 
2 (14). However, the cell types
acting as a source of LT
 
 
 
1
 
 
 
2 in T zone stromal cell devel-
opment have not been defined.
We demonstrate here that splenic expression of CCL21
is dependent on the presence of B cells but not T cells,
whereas expression in lymph nodes is B cell independent.
By immunohistochemistry, B cell–deficient spleens have a
three- to fivefold reduction in the area stained by CD3 and
by the T zone stromal cell marker, gp38 (15). In addition
to the role of LT
 
 
 
1
 
 
 
2 in promoting T zone chemokine
expression, we find that LT
 
 
 
1
 
 
 
2 is required for T zone
gp38 expression. Bone marrow transfer and LT
 
 
 
R-Ig
blocking experiments indicate a developmentally fixed role
for B cells and LT
 
 
 
1
 
 
 
2 in promoting splenic T zone
development. We show that the expression of LT
 
 
 
1
 
 
 
2 on
B cells is sufficient to restore splenic DC numbers in LT
 
 
 
-
deficient mice. The presence of normal numbers of splenic
T cells in LT
 
 
 
-deficient mice (16–19) demonstrates that B
cell regulation of splenic T cell numbers is mediated by
LT
 
 
 
1
 
 
 
2-independent pathways. These findings indicate a
prominent role for B cells in providing LT
 
 
 
1
 
 
 
2 and other
signals needed for development of T zones and accumula-
tion of DCs and T cells in the spleen.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) 
 
 
 
MT (BCR
 
 
 
/
 
 
 
), B6 TCR
 
 
 
 
 
/
 
 
 
 
 
 
 
/
 
 
 
(TCR
 
 
 
/
 
 
 
), B6/129 LT
 
 
 
 
 
/
 
 
 
, and B6 recombination activating
gene (RAG)-1
 
 
 
/
 
 
 
 mice were from The Jackson Laboratory. For
generation of bone marrow chimeras, 1–5 
 
  
 
10
 
6
 
 total bone mar-
row cells were intravenously injected into lethally irradiated re-
cipient mice (1,100 rads). Recipient mice were given antibiotic
water (polymyxin B, 110 mg/liter and neomycin, 1.1 g/liter)
during the 6–10-wk reconstitution period, before analysis. For
splenocyte transfers, cell enumeration experiments and DC analy-
sis, cells were prepared by gently pressing the spleen through a
70-
 
 
 
M mesh cell strainer (Fisher Scientific). Red blood cells was
lysed and cells were resuspended in serum-free DMEM contain-
ing antibiotics. In some cases, spleen cell suspensions were pre-
pared using collagenase and EDTA, as previously described (20).
2 
 
  
 
10
 
7
 
 splenocytes in a volume of 0.05 ml were injected into
the peritoneal cavity of newborn mice with a 30-gauge needle as
described previously (21). Treatment with LT
 
 
 
R-Ig or human
LFA3-Ig was by intraperitoneal injection as described previously
(14), using 100 
 
 
 
g per injection.
 
Generation of 
 
 
 
LT
 
 
 
-Transgenic Mice.
 
A DNA fragment en-
coding the transmembrane and membrane-proximal (stalk) re-
gions of the LT
 
 
 
 gene (22, 23), corresponding to nucleotides
1–450 (GenBank/EMBL/DDBJ accession no. U16985) was iso-
lated by PCR from spleen cDNA using primers 5
 
 
 
-TAGTA-
GGGATCCGATATCCTGGATGGGGACACGGGGACT-3
 
 
 
(containing a 5
 
 
 
 BamHI and EcoRV sites) and 5
 
 
 
-TAGT-
AGGTCGACATCATCATCATCTTTGTAATCGTTGAGG-
3
 
 
 
 (containing a 3
 
 
 
 SalI site). A fragment containing nucleotides
124–609 (GenBank/EMBL/DDBJ accession no. M16819) of LT
 
 
 
,
encoding for the receptor-binding domain (24), was isolated with
 
the primers 5
 
 
 
-TAGTAGGTCGACCATGGCATCCTGAAA-
CCTGCT-3
 
 
 
 (with SalI site) and 5
 
 
 
-TAGTAGATCGATGCG-
GCCGCCTACAGTGCAAAGGCTCC-3
 
 
 
 (with NotI and ClaI
sites). The PCR fragments were cloned into pEF-BOS-XC (25)
and an EcoRV-NotI fragment containing the LT
 
 
 
-LT
 
 
 
 chi-
meric gene was isolated and cloned into end-blunted ClaI and
NotI sites of the pBXD1 vector. PBXD1 was generated by com-
bining the 2.1-kb Ig 
 
 
 
-promoter fragment from myeloma S107
in series with: (a) a 0.24 kb 5
 
 
 
 chimeric intron from the pCI vec-
tor (Promega), (b) a multiple cloning site, (c) the 0.2 kb late SV40
poly A sequence, and (d) both 2.1 kb 
 
 
 
 MAR/intron enhancer
and 1.3 kb 3
 
 
 
 enhancer regions from the Balb/c 
 
 
 
 gene. The
BamHI and EcoRI linearized chimeric LT
 
 
 
/LT
 
 
 
 minigene was
microinjected into fertilized (C57BL/6J 
 
  
 
DBA/2J)F2 oocytes
according to standard techniques. To screen for transgenic mice,
ear DNA was prepared and the transgene was detected by PCR
using the above indicated primer pairs. Founder #4 was crossed
with B6 LT
 
 
 
-deficient mice (26) to generate 
 
 
 
LT-transgenic/
LT
 
 
 
 
 
/
 
 
 
 mice. To distinguish the LT
 
 
 
-targeted and wild-type
alleles by PCR, a mixture of the following primers were used
5
 
 
 
-TAGTAGGTCGACATGACACTGCTCGGCCGTCT-3
 
 
 
(LT
 
 
 
-specific), 5
 
 
 
-GCTTGCCGAATATCATGGTGG-3
 
 
 
 (Neo-
specific), and 5
 
 
 
-GGACAGAAGAGAGTGGAGAGG-3
 
 
 
 (LT
 
 
 
-
specific), yielding a 
 
 
 
180-bp fragment from the wild-type allele
and a 
 
 
 
380-bp fragment from the targeted allele. Amplification
conditions were 94
 
 
 
C for 30 s, 55
 
 
 
C for 30 s, 72
 
 
 
C for 60 s, for
40 cycles. All the transgenic mice characterized were heterozy-
gous for the transgene. The transgenic animals appeared healthy
and grew equivalently to their littermate controls.
 
Northern Blot Analysis.
 
10–15 
 
 
 
g of total RNA from mouse
spleens or lymph nodes was subjected to gel electrophoresis,
transferred to Hybond N
 
 
 
 membranes (Amersham Pharmacia
Biotech), and probed using randomly primed 
 
32
 
P-labeled mouse
cDNA probes of the following types: CCL21, bases 1–848 (27)
and CCL19, bases 1–755 (28). To control for RNA loading, a
mouse elongation factor 1
 
 
 
 (EF1
 
 
 
) probe was used. For quantita-
tion, Northern blots were exposed to a phosphor screens for 6 h
to 3 d and images were developed using a Storm860 Phosphor-
Imager (Molecular Dynamics). Data were analyzed using Im-
ageQuant
 
®
 
 software (Molecular Dynamics), and chemokine
mRNA levels were corrected for RNA loaded by dividing the
chemokine hybridization signal by the EF-1
 
 
 
 signal for the same
sample. Relative expression levels were calculated by dividing the
corrected signal for each mutant or treated sample with the mean
corrected signal for the wild-type or control treated samples, as
appropriate, that were included on each of the Northern blots.
 
Immunohistochemistry.
 
Cryostat sections (6–7 
 
 
 
m) were fixed
and stained as described previously (29) using the following
mAbs: rat anti-B220 (CalTag); rat anti-MAdCAM-1 (BD
PharMingen); goat anti-mouse 6Ckine (CCL21; R&D Systems);
sheep anti-IgD (BD PharMingen); and syrian hamster anti-gp38
(provided by Andrew Farr, University of Washington, Seattle,
WA). Rat IgG antibodies were detected with goat anti–rat-IgG
conjugated alkaline phosphatase (AP; Southern Biotechnology
Associates, Inc.) or donkey anti–rat-IgG conjugated horseradish
peroxidase (HRP). Goat IgG antibodies were detected with bio-
tinylated donkey anti–goat (Southern Biotechnology Associates,
Inc.), followed by Vectastain ABC-AP (Vector Laboratories).
Sheep IgG antibodies were detected with donkey anti–sheep-IgG
HRP (Jackson ImmunoResearch Laboratories). Syrian hamster
IgG antibodies were detected with anti-syrian hamster-AP (Jack-
son ImmunoResearch Laboratories). Enzyme reactions were de-
veloped with conventional substrates for peroxidases (diami- 
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nobenzidine/H
 
2
 
O2; Sigma-Aldrich) and AP (FAST BLUE/
Naphthol AS-MX; Sigma-Aldrich). For measuring T zone and
red pulp areas, cross-sections were made through central seg-
ments of the spleen, stained for gp38, CD3, or B220, analyzed at
5  objective magnification, and digital images of a fixed resolu-
tion were acquired using a cooled MDEI850 CCD camera (Op-
tronics Engineering). Using Adobe Photoshop® software, an out-
line was drawn around positively stained areas using the lasso tool
and the total pixels within each lassoed area were obtained using
the histogram function. Data were collected from a minimum of
two cross-sections per spleen. The total number of pixels was
then divided by the number of spleen cross-sections analyzed to
provide a measurement of pixel counts per cross-section. Pixel
counts for red pulp areas were obtained by subtracting the CD3 
areas (for BCR   ), or B220  areas (for wild-type) from the total
splenic cross-sectional area obtained by lassoing the entire spleen
cross-section.
Results
B Cells Regulate Splenic T Zone Chemokine Expression.
To examine the cellular requirements for expression of the
T zone chemokines, CCL21 (SLC) and CCL19 (ELC), we
performed Northern blot analysis of spleen and lymph
node tissue from B- and T cell–deficient mice. Surpris-
ingly, expression of CCL21 in spleen was strongly depen-
dent on B cells but not on T cells (Fig. 1, A and B).
Splenic CCL19 mRNA expression was less affected by
lymphocyte deficiency and showed a slightly greater de-
pendence on B cells than T cells (Fig. 1, A and C). Lym-
phocytes are not a significant source of CCL19 or CCL21
(27, 28). Therefore, the absence of B and/or T lympho-
cyte RNA in the mutant spleens cannot explain the reduc-
tion in chemokine mRNA and instead may cause the
magnitude of the reduction to be underestimated. The de-
crease in CCL21 in B cell deficient spleen was also evident
by in situ hybridization and immunohistochemical analysis
(data not shown). In contrast to spleen, CCL21 mRNA
expression in LNs was not affected by B cell deficiency
(Fig. 1 E). T cells were also not required for CCL21 ex-
pression in lymph nodes (Fig. 1 E). Similarly, lymph node
CCL19 expression was not dependent on the presence of
B cells or T cells (Fig. 1 F). Previous studies established
that splenic expression of the B zone chemokine,
CXCL13, is dependent on B cells but not on T cells (14)
and we find here, in contrast to CCL21, that CXCL13
mRNA expression in lymph nodes is also B cell dependent
(Fig. 1 D). In summary, B cells promote CCL21, and to a
lesser extent CCL19, expression in spleen but not in
lymph nodes, whereas they promote CXCL13 expression
in both types of lymphoid tissues.
Requirement of B Cells for Splenic Stromal Cell Maturation
and T Cell and DC Accumulation. Recent experiments
have established that T zone stromal cells are the major
source of CCL21 in the spleen (11). To test whether B
cells influenced other properties of the T zone stromal cell
network, we stained spleen sections for gp38 (Fig. 2), a
membrane glycoprotein that is selectively expressed by
these cells (15). Strikingly, there was a four- to fivefold de-
crease in the area of gp38 staining in B cell–deficient
spleen compared with wild-type (Fig. 2 and Fig. 3 A),
whereas gp38 staining in LNs was unaffected by B cell de-
ficiency (Fig. 2). Concordant with the decreased area of
gp38  T zone stromal cells, measurements of T zone
cross-sectional area using anti-CD3 revealed a two- to
threefold decrease (Fig. 3 A). By contrast, the red pulp
cross-sectional area was equivalent in B cell–deficient and
wild-type spleens (Fig. 3 B). These findings led us to
quantitate T cell numbers in B cell–deficient spleens. Pre-
vious studies of B cell–deficient mice have either not re-
ported an effect on splenic T cell numbers (30–32) or
reported a decrease (33). Careful enumeration of cell
numbers in spleens from specific pathogen-free, age-
matched wild-type and B cell–deficient mice revealed that
CD4 and CD8 T cells were reduced by threefold in B
cell–deficient spleens (Fig. 3 D). The number of CD11c 
DCs was also diminished (Fig. 3 F) in agreement with
findings by some (34) but not others (35). Consistent with
the poor lymphoid cellularity, B cell–deficient spleens
were about half the weight of their wild-type counterparts
(data not shown). The decreases were selective to the
Figure 1. Reduced expression of splenic T zone chemokines in B cell–
deficient mice. (A) Northern blot analysis of total RNA isolated from
spleen tissue of the indicated mice, probed to detect expression of CCL21
(SLC) and CCL19 (ELC). Hybridization to EF1  was used to control for
RNA loaded. WT, wild-type. (B–F) Relative chemokine mRNA levels
in spleen or mesenteric lymph node (MLN) RNA, determined by Phos-
phorImager analysis of multiple Northern blots, including blots probed
for CXCL13 (BLC). Data from individual mice are shown as circles and
means as bars.1652 B Cell–derived LT 1 2 Promotes Spleen T Zone Development
spleen as B cell–deficient mice had normal numbers of T
cells in lymph nodes (Fig. 3 E).
LT Is Required for Splenic T Zone Development. Mice
lacking the genes for LT  or LT , that are unable to express
LT 1 2, are severely deficient in CCL21 and CCL19 ex-
pression (14). Analysis of gp38 revealed that expression of
this T zone stromal cell marker is strongly dependent on
LT  (Fig. 2) and LT  (data not shown). Collectively, these
findings establish that LT 1 2 is required for splenic T zone
stromal cell development or maturation. In agreement with
this role, T cells fail to accumulate normally in T cell areas in
LT -deficient mice (14, 36). However, many T cells are
distributed in the red pulp and, in contrast to B cell–deficient
spleens, T cell numbers in LT  /  spleens are in the range
of wild-type (16–18). Therefore, separate signals appear to
be involved in regulating T cell numbers in the spleen versus
induction of T zones within the white pulp cords.
Figure 2. GP38-expressing stromal cell networks are small in B cell–
deficient spleens and undetectable in LT -deficient spleens. Spleen and
lymph node tissue from wild-type (WT), B cell-deficient (BCR / ), and
LT  /  mice, as indicated, was sectioned and stained to detect gp38
(blue) and IgD (brown). No lymph nodes were found in the LT  /  an-
imal. The bottom left panel demonstrates the method used for measuring
gp38  cross-sectional areas, showing the BCR /  spleen cross-section
with gp38  stained areas ‘lassoed’ and the number of pixels present in the
single fully identified gp38  area indicated. Original objective magnifica-
tion for all panels:  5. Data are representative of tissues from more than
10 animals of each type.
Figure 3. B cells promote splenic T zone stromal cell development and
accumulation of splenic T cells and DCs. (A) Cross-sectional areas of
gp38- and CD3 staining in B cell–deficient and wild-type (WT) spleens.
Positively stained areas were determined as indicated in Fig. 2 and the
numbers of pixels per splenic cross-section was calculated using Adobe
Photoshop® software as described in Materials and Methods. Data were
collected from seven wild-type and seven BCR /  spleens. (B) Cross-
sectional area of red pulp in B cell–deficient and wild-type spleens. Pixel
counts were determined as in A, and red pulp areas were obtained by sub-
tracting the white pulp areas (identified as the outer boundaries of CD3
and B220 staining) from the total splenic cross-sectional area. Data were
collected from 12 spleens of each type. (C–E) Cell numbers in spleen, pe-
ripheral lymph nodes (pool of brachial, axillary, and inguinal) and blood.
Cells were identified by flow cytometry as CD3 CD4 , CD3 CD8 , or
MHC classII CD11c . Data are from 8–11 mice per group. In all panels,
open bars correspond to wild-type and shaded bars to B cell deficient.
Bars represent means and error bars, standard deviations. Statistical com-
parison is by Student’s t test.1653 Ngo et al.
B cells have previously been established to function as a
source of LT 1 2 necessary for FDC development (9, 10,
37). To test whether B cell–derived LT 1 2 is required
for splenic T zone development, we first asked whether
constitutive LT 1 2 signaling was important for maintain-
ing CCL21 expression. Previous studies indicated that
blocking LT 1 2 signaling in adult mice using LT R-Ig
treatment reduced CCL21 levels by  30% (14); however,
it was unclear in these studies whether all LT 1 2 function
had been blocked. Therefore, we took a further approach
to test for the requirement for LT 1 2, reconstituting le-
thally irradiated adult mice with LT -deficient bone mar-
row. Despite efficient reconstitution by donor-derived cells
(data not shown), CCL21 expression was not strongly af-
fected compared with animals reconstituted with wild-type
bone marrow (Fig. 4 A). Similar findings were made when
lethally irradiated mice were reconstituted with BCR / 
or RAG1 /  bone marrow (data not shown). By contrast,
CXCL13 levels were reduced to  40% of wild-type (Fig.
4 A). Reciprocally, when lymphocyte-deficient mice were
reconstituted with wild-type bone marrow, they failed to
upregulate CCL21 expression (Fig. 4 B), whereas substan-
tial upregulation of CXCL13 was observed (Fig. 4 B).
Taken together, these results suggest that the strong deficit
in CCL21 in mice congenitally deficient in LT 1 2 or B
cells reflects a role for B cells and LT 1 2 in inducing
CCL21 during a fixed window in spleen development.
B lymphocytes begin seeding the spleen soon after birth
(38, 39), and consistent with an ability of B cells to have
early postnatal effects, intraperitoneal transfer of TCR  / 
  /  spleen cells to RAG1 /  mice shortly after birth was
sufficient to lead to an increase in CCL21 expression, mea-
sured in the spleen 5 wk later (Fig. 4 C). B cell numbers
were only restored to between 1 and 10% of wild-type by
this approach, and this may account for the incomplete up-
regulation of CCL21 expression. Importantly, if the trans-
ferred cells lacked LT , they failed to cause an upregula-
tion in CCL21 (Fig. 4 C).
As a further approach to test the requirement of LT 1 2
early in life for T zone chemokine expression, newborn or
1-wk-old wild-type mice were treated with LT R-Ig and
then the treatment was either stopped or continued as the
animals grew to become adults. Analysis of spleen tissue
from 5-wk-old animals given continuous injections of
LT R-Ig from birth showed a striking inhibition of
CCL21 expression (Fig. 5 A), an effect markedly greater
than the  30% decrease observed after treating adult ani-
Figure 4. B cell and LT  dependence of
splenic T zone stroma is developmental. (A)
Relative CXCL13 or CCL21 mRNA levels
in spleen, as determined by Northern blot,
of wild-type (WT) or LT -deficient mice,
or irradiated wild-type mice 6 wk after re-
constitution with WT or LT  /  bone
marrow. (B) Relative CXCL13 or CCL21
mRNA levels in spleen of WT or RAG1-
deficient mice, or irradiated RAG1-defi-
cient mice 6 wk after reconstitution with
WT or RAG1-deficient bone marrow. (C)
Relative CCL21 mRNA levels in spleen of
6-wk-old RAG1-deficient mice or
RAG1 /  mice that were injected intra-
peritoneally (i.p.) with 2   107 splenocytes
from adult T cell-deficient (TCR / ) or
LT -deficient mice at day 0.5 after birth. B
cell numbers in spleens at isolation were be-
tween 0.7–3.106 (TCR /  recipients) or 1.0–2.5   106 (LT  /  recipients). Each circle represents an individual recipient and bars represent means.
White bars, wild-type, black bars, LT  /  or RAG1 / , shading, mice reconstituted with wild-type bone marrow or TcR /  spleen cells, hatched bars,
mice reconstituted with mutant bone marrow or LT  /  spleen cells. Statistical comparison is by Student’s t test.
Figure 5. LT 1 2 antagonism in newborn mice inhibits CCL21 up-
regulation. (A) Relative CCL21 mRNA levels in spleen of 5-wk-old
mice that were treated at day 0.5 (wk 0), days 7, 14, 21, and 28 (wk 1–4)
or days 0.5, 7, 14, 21, and 28 (wk 0–4) after birth with LFA3-Ig or
LT R-Ig, as indicated. Each circle represents an individual animal and
bars represents means. (B) Representative flow cytometric profiles of
spleen cells from 5-d-old mice stained to detect B cells (CD19) and
LT R ligands (LT R-Ig). In the bottom panel, the cells were preincu-
bated with unconjugated anti-LT  antibody that inhibits LT R-binding
to LT 1 2 as a staining control. The mean percentage of B cells falling
within the gate indicated by the filled box is indicated (  SD) for cells
from three 5-d-old mice.1654 B Cell–derived LT 1 2 Promotes Spleen T Zone Development
mals with the antagonist for a similar period (14). In further
agreement with a role for LT 1 2 early in spleen T zone
development, CCL21 levels were strongly reduced in ani-
mals treated with a single injection of LT R-Ig at day 0.5
of life (Fig. 5 A). Although the LT R-Ig is likely to have
persisted in the serum of these animals for several weeks
(40), the importance of LT 1 2 signaling during the first
week after birth is supported by the lesser effect on CCL21
levels when the treatment was delayed until week one (Fig.
5 A). Strikingly, immunohistochemical analysis of spleens
from mice treated at day 0.5 revealed a severe disruption in
organization and failure to express gp38 (Fig. 6 A), a phe-
notype similar to congenic LT -deficiency (see Figs. 2 and
6 B). When the antagonist treatment was delayed until day
7, the effect was much less severe as white pulp cords with
gp38  T cells areas could be identified (Fig. 6 A). In agree-
ment with B cells serving as a source of LT 1 2 in the
early postnatal period, flow cytometric analysis of B cells
from day 5 spleens showed that, despite having the
expected IgDloCD21lo immature phenotype (data not
shown), they expressed measurable surface LT 1 2 as as-
sessed by staining with LT R-Ig (Fig. 5 B), although the
fraction of positively stained B cells was two- to threefold
lower than in adult spleen (7). In summary, these findings
suggest that B cells promote CCL21 upregulation and
splenic T zone development at least in part by acting as a
source of LT 1 2 in the neonate.
Selective Expression of LT 1 2 in B Cells Is Sufficient to
Promote Splenic CCL21 Expression, White Pulp T Zone De-
velopment, and Splenic DC Accumulation. The develop-
mentally fixed requirement for LT 1 2 made it difficult to
use adoptive transfer approaches to test whether B cells
Figure 6. LT 1 2 antagonism in newborn mice inhibits T zone stromal cell development, and transgenic expression of LT 1 2 on B cells rescues T
zone development in LT -deficient mice. (A) Spleen tissue from mice treated with control (hLFA3-Ig) on days 0.5, 7, 14, 21, and 28 (left panel), or with
LT 1 2 antagonist (LT R-Ig) on day 0.5 (center panel) or days 7, 14, 21, and 28 (right panel), stained to detect B220 (brown) and gp38 (blue). (B)
Spleen tissue from wild-type, LT -deficient or LT -deficient carrying the  LT  transgene ( LT -tg/LT  / ) stained in brown to detect B220 (all
panels) and in blue to detect CCL21 (top panels) and gp38 (bottom panels). Data are representative of more than four animals of each type. Note that the
faint blue signal in the red pulp of the panels in A and the upper LT  /  panel in B was due to background staining and was also observed in sections
stained with control antibodies.1655 Ngo et al.
were a sufficient source of this cytokine for T zone devel-
opment. As a further strategy to test this issue, we produced
mice that selectively express LT 1 2 on B cells (Fig. 7).
Transgenic animals were made that carry the coding region
of the LT  gene fused to the segment of the LT  gene en-
coding the membrane and spacer domains (23). We chose
to make a membrane bound form of LT  to reduce the
likelihood of soluble LT  being released and functioning at
distal sites, either as LT 3 homotrimer or by restoring
LT 1 2 in trans, phenomena that appeared to occur in
mice overexpressing soluble LT  in the pancreas (41). Ex-
pression of the chimeric LT  gene was placed under con-
trol of the Ig   enhancer and promoter elements to provide
B cell–specific expression (Fig. 7 A).
Previously, we have observed that membrane LT 1 2
on B cells is unstable and is lost as cells enter circulation (7).
We expected that the membrane form of LT  encoded by
the transgene would increase the stability of the LT 1 2
and, consistent with this, we were able to identify trans-
genic founders by elevated LT 1 2 expression on blood B
cells (Fig. 7 B, and data not shown). One transgenic line
was selected that exhibited a level of LT R-Ig staining on
blood B cells that was similar to the level of staining of
splenic B cells in wild-type animals and this line was inter-
crossed with LT -deficient mice. Analysis of splenocytes
from these mice showed surface LT 1 2 expression on B
cells at levels  2–3-fold above wild-type controls (Fig. 7
B) and no measurable expression on T cells, CD11c  cells,
or gran-1  cells (Fig. 7 B, and data not shown). The trans-
genic cells did not stain detectably with TNFR1-Ig, indi-
cating that there was little or no generation of functional
surface LT 3 homotrimers (data not shown). Consistent
with B cell–restricted expression, the transgene failed to re-
store lymph node or Peyer’s patch development in the
LT -deficient animals (data not shown). However, there
was a striking restoration of spleen architecture compared
with LT -deficient animals. T cells accumulated in well
developed T cell areas, and these zones showed strong ex-
pression of CCL21 (Fig. 6 B, top panels). The T cell areas
also exhibited extensive networks of gp38  T zone stromal
cells, although the distribution of staining often differed
from wild-type spleen, with a higher concentration of
gp38  cells near the boundary of B and T zones (Fig. 6 B,
middle panels). B cell regions were also present in the
transgenic animals (Fig. 6 B) and they contained CD35 
follicular stromal cells (data not shown). By Northern blot,
expression of LT 1 2 selectively on B cells restored
CXCL13 to wild-type levels and caused CCL21 to be ex-
pressed somewhat above wild-type controls (Fig. 7 C).
Furthermore, expression of LT 1 2 on B-lineage cells was
also sufficient to restore splenic DC numbers (Fig. 7 D).
The DCs appeared to have a wild-type localization, with
cells distributed in the marginal zone, marginal zone bridg-
ing channels, and in T cell areas, although in some cases
clusters were also detected in the red pulp (data not
shown). In summary, these findings provide strong evi-
dence that B cells can act as a sufficient source of LT 1 2
to promote development of the splenic T zone and to
cause accumulation or development of splenic DCs.
Discussion
In the above studies, we demonstrate that B cells play a
critical role in splenic, but not lymph node, T zone devel-
opment. In mice lacking B cells, splenic gp38  T zone
Figure 7. Transgenic restoration of LT 1 2 on B cells in LT -defi-
cient mice promotes splenic CCL21 and CXCL13 expression and DC ac-
cumulation. (A) A schematic diagram of the membrane LT  transgenic
construct. See Materials and Methods for details. TMD, transmembrane
domain; MAR, matrix-attachment region; E, enhancer. (B) Representa-
tive flow cytometric profiles of LT R-Ig binding of B220  B cells from
blood and spleen of WT, LT  / , and  LT -transgenic/LT  /  mice as
indicated. (C) Relative CCL21 and CXCL13 mRNA levels in spleen tis-
sue from the indicated mice. Each circle represents an individual animal
and bars represents means. (D) Flow cytometric profiles of CD11c stain-
ing in the indicated mice. Profiles are representative of four mice of each
type and are for spleen cells prepared in the absence of collagenase. Anal-
ysis of two further spleen samples that had been prepared with collagenase
revealed greater frequencies of CD11c  cells, and continued to show res-
toration of CD11c  cell frequency in the  LT -tg/LT  /  animals.1656 B Cell–derived LT 1 2 Promotes Spleen T Zone Development
stromal cells fail to develop into their normal extensive net-
work, and T zone CCL21 expression is markedly reduced.
Our findings indicate that B cells promote splenic T zone
stromal cell development and chemokine expression at least
in part by acting as a source of LT 1 2. This function of B
cells is largely a fixed, developmental role. We also find that
B cell–derived LT 1 2 promotes splenic DC accumula-
tion or development. Furthermore, B cells are needed for
accumulation of normal numbers of T cells in the spleen.
Previous studies have indicated that LT 1 2 and T zone
chemokines, CCL19 (ELC) and CCL21 (SLC), are not re-
quired for T cell accumulation in the spleen (16–18, 42).
Therefore, we conclude that B cells provide at least two
types of signals necessary for normal spleen organogenesis:
(a) signals that promote CD4 and CD8 T cell accumulation
in the spleen, and: (b) signals, including LT 1 2, that reg-
ulate properties of white pulp stromal cells and promote
development of T zones and development or accumulation
of DCs.
T zone stromal cells have been characterized as a popula-
tion of mesenchymal cells that are distributed throughout
lymphoid organ T zones (15, 43). The recent finding that
these cells are a major source of CCL21 and CCL19 has
suggested that they play a central role in bringing CCR7-
positive T cells and DCs together (11). Previously, using
the white-pulp stromal cell marker BP3, we provided evi-
dence that T zone stromal cell maturation was dependent
on LT 1 2 (14). Other studies have indicated that there
are alterations in the expression pattern of the T zone and
red-pulp stromal marker, ER-TR7, in LT-deficient or de-
pleted mice (18, 44, 45). We show here that expression of
gp38, a marker that is thought to stain the majority of T
zone stromal cells (15), is also LT 1 2-dependent. There-
fore, LT 1 2 appears to be critical for development of T
zone stromal cells and, in turn, for the development of or-
ganized splenic T cell zones (Fig. 8).
Several lines of evidence indicate a requirement for
LT 1 2 in splenic T zone development that is fixed dur-
ing the first few weeks after birth. First, in contrast to the
severely defective splenic T zones of mice congenitally de-
ficient in LT 1 2, in studies where LT 1 2 function was
blocked in adult animals, effects on T zone organization
were minimal (45) and T zone chemokine expression was
only mildly diminished (14). Second, when adult mice are
depleted of LT -expressing cells by irradiation and recon-
stitution with LT -deficient bone marrow, T zones remain
visible (data not shown and see reference 46) and there is
little reduction in CCL21 expression (Fig. 4). Therefore,
once the splenic CCL21-expressing T zone stromal net-
work has developed, it has only a weak requirement for
continued LT R-signaling to be maintained. By contrast,
treatment of newborn mice with LT 1 2 antagonist had a
marked inhibitory effect on subsequent CCL21 and gp38
expression in the adult (Figs. 5 and 6). Interestingly, the ef-
fect of LT R-Ig treatment on the first day after birth was
also more severe than in utero treatment at day 14 and 17
of embryogenesis (40, 47). This suggests that, in contrast to
the critical embryonic function of LT 1 2 in lymph node
development (36), most of the organizing activity of
LT 1 2 in the spleen occurs after birth. Although experi-
ments involving treatment with LT R-Ig do not rule out
involvement of the second known LT R ligand, LIGHT,
the similarities between the effect of LT R-Ig treatment
and LT - and LT -deficiency (36) argue that the principal
pathway involved in promoting splenic white pulp organi-
zation is the LT 1 2-LT R pathway.
The finding that T zone development is dependent on
both LT 1 2 and B cells, together with the previous dem-
onstration that B cells are a source of LT 1 2 (7, 9, 10,
37), led to the prediction that B cells act as the major
source of this cytokine for splenic T zone development.
Consistent with this, B cells enter the spleen in the first few
days after birth and during this period the cells are located
around central arterioles, in regions destined to become T
cell areas (38, 39). Later, B cells continuously migrate
through the outer T zone as they traffic to B cell areas (4).
Immature B cells in the developing spleen were found to
have low but measurable surface LT 1 2 (Fig. 5) and
transfer of wild-type B cells, but not LT -deficient cells, to
newborn lymphocyte-deficient mice was sufficient to up-
regulate splenic CCL21 (Fig. 4). Furthermore, transgenic
expression of LT  under control of Ig-kappa promoter and
enhancer elements restored splenic CCL21 (and also
CXCL13) expression and led to development of gp38  T
zone stromal cell networks in LT -deficient mice (Figs. 6
and 7). Therefore, several different findings support the
conclusion that B cells act as a critical source of LT 1 2 in
splenic T zone development. A model incorporating these
findings is shown in Fig. 8.
Figure 8. Model of splenic T
zone development in the mouse.
Step 1, occurring in the days before
and around the time of birth,
LT R  mesenchymal cells proximal
to splenic arterioles acquire some
features of T zone stromal cells by
unknown mechanisms. These cells
produce low levels of CCL19 (not
shown) and CCL21 in a LT 1 2-
independent manner. Step 2, occur-
ring in the first days to a few weeks
after birth, newly produced B cells
arrive in the spleen and express sur-
face LT 1 2, possibly in response to
CCL19 and CCL21 (reference 7),
but likely also in response to other
signals, and induce LT R-signaling
in the primitive stromal cells. These
signals may act directly to promote
growth (possibly involving cell division) of the stromal cell network and
to increase expression of CCL21, gp38 and, to a lesser extent, CCL19.
Alternatively, the signals may act indirectly, through intermediary
LT R  cell types to cause these outcomes. It is also possible that the ef-
fects of LT 1 2 and B cells on chemokine and gp38 expression do not
reflect direct induction but are secondary to growth of the T zone stromal
network. Furthermore, cells in addition to B cells may contribute
LT 1 2, especially for induction of gp38 as this marker is expressed at
higher amounts in B cell–deficient animals than in LT -deficient animals.
Step 3, T cells and DCs are recruited to the network of CCL21 and
CCL19 producing stromal cells and the mature T zone forms.1657 Ngo et al.
A question that arises from these findings is whether B
cells function as the only source of LT 1 2 required for
splenic T zone development. Arguing against this is the
Northern blot analysis of CCL21, which indicates that
mRNA levels are reduced 5–10-fold in B cell–deficient
spleen compared with  20-fold in LT -deficient spleen
(14; Figs. 1 and 4). In addition, Gonzalez et al., found that
pretreatment of SCID mice with LT R-Ig influenced the
subsequent ability of transferred B and T cells to organize
within the white pulp (10). Recently, a hematopoietic cell
type, characterized as CD4 CD3 IL7R  LT 1 2 , has
been implicated in the earliest steps in lymph node and
Peyer’s patch development (48–50). As we have not found
a role for B cells or T cells in lymph node T zone stromal
cell development (Figs. 1 and 2), we favor a model where
CD4 CD3  cells provide the necessary LT 1 2 signals.
By contrast with lymph nodes, CD4 CD3  cells are very
infrequent in embryonic spleen and they have so far not
been implicated in spleen development (48, 50, 51). In ad-
dition, we have shown that T cells are not needed as a
source of LT 1 2 for induction of splenic CCL21. Future
studies need to investigate what other cell types express
LT 1 2 in the developing spleen. However, our studies
are also consistent with the possibility that in normal ani-
mals, B cells act as a sufficient source of LT 1 2 for spleen
development and the contributions of other cell types only
become evident when B cells are absent. Interestingly, in
the transgenic animals constitutively expressing LT 1 2
on B cells, the pattern of gp38  T zone stromal cell net-
works is well developed but differs from wild-type by
showing higher amounts of staining at B/T-zone bound-
aries (see Fig. 6). In addition, although B cell areas develop,
they fail to form the highly polarized clusters typical of
wild-type follicles (Fig. 6, and data not shown). A likely
explanation for these differences is the altered regulation of
LT 1 2 expression in B cells. In wild-type animals, we
have provided evidence that LT 1 2 expression on B cells
is cyclical, being induced by CXCL13 to maximal levels as
B cells migrate into the FDC networks and then being
downregulated as cells pass into the blood (7). By contrast,
in the transgenic animals the expression is constitutive and
divorced from normal regulatory controls, and B cells at
the B/T boundary are likely to express the same high levels
of LT 1 2 as cells within the CXCL13-producing FDC
networks. While further study of the transgenic animals is
needed, these observations provide support for the conclu-
sion that cyclical expression of LT 1 2 on migratory B
cells is important for the formation and maintenance of pat-
tern in lymphoid tissue.
The ability of B cells to promote development of T
zones in a LT 1 2-dependent manner was previously sug-
gested by the finding that ectopic expression of CXCL13
in the pancreas caused recruitment of B cells and develop-
ment of lymph node like structures, with T cell areas con-
taining stromal cells, DCs and CCL21 (52). Such ectopic T
cell areas did not develop in mice lacking B cells and antag-
onism of LT 1 2 function was sufficient to block T zone
development (52). However, in contrast to the ectopic sys-
tem, CXCL13 is not required for promoting splenic T
zone development as these areas develop normally in
CXCL13-deficient mice (7), and splenic CCL21 levels are
unaffected by CXCL13 deficiency (unpublished observa-
tions). Perhaps another lymphoid tissue–expressed chemo-
kine that is capable of upregulating LT 1 2 on B cells (7)
plays this role during spleen development. The findings
here and in the RIP-BLC system indicate that there are
several pathways by which B cells can be induced to ex-
press LT 1 2 and to promote T zone development.
In addition to their requirement for development of T
zone stromal cells, B cells (34; Fig. 2) and LT 1 2 (19) are
required for normal accumulation of DCs in the spleen.
Our findings provide evidence that B cells can function as a
sufficient source of LT 1 2 for promoting normal DC ac-
cumulation in the spleen. Consistent with an important
role for B cells in regulating splenic DC development, a re-
cent report found that DCs from B cell–deficient spleens
were functionally distinct from DCs taken from wild-type
spleens (53). The origin of splenic DCs is not well defined.
While some may derive directly from precursors in the
blood or from DCs that have entered the blood, for exam-
ple, from the heart or liver, there is also evidence that
splenic DCs can develop locally from precursors in the
spleen (54–56). LT R expression has been reported in my-
eloid-lineage cells (57, 58), making it possible that B cell
LT 1 2 acts directly on DC precursors. Alternatively, B
cell–mediated induction of white pulp stromal cell matura-
tion may indirectly promote DC development or may al-
low the survival of more DCs to be supported. It is un-
likely that the effect of B cells on DC numbers is through
effects on CCL21 or CCL19 as mice that lack these che-
mokines in lymphoid tissues have normal numbers of
spleen DCs (11, 12), but it remains possible that B cells
promote DC homing to the spleen through effects on
other chemokines or trafficking molecules.
The finding that B cells were needed in the spleen for
normal T zone stromal cell development and chemokine
expression, and for normal accumulation of CD4 and CD8
T cells initially led us to consider that these processes were
linked. However, this does not appear to be the case as an-
imals that lack LT  or LT  contain approximately normal
numbers of T cells in the spleen (16–18). The plt mouse
strain, lacking lymphoid CCL19 and CCL21 expression,
also has normal numbers of splenic T cells (12). In both
types of animal, the T cells are distributed mostly in the red
pulp. A complication with these studies is that these ani-
mals either lack or have a severe paucity of T cells in lymph
nodes, possibly leading to an indirect effect on T cell num-
bers in the spleen. However, we have found that when B
cell–deficient mice are reconstituted with wild-type bone
marrow or are restored as adults with a transfer of B cells,
spleen size grows and T cell numbers reach normal levels
(data not shown) despite the failure to upregulate CCL21
expression in spleen (Fig. 4). Therefore, the findings sug-
gest a dissociation between B cell effects on T zone stromal
cell development, CCL21 expression and DC accumula-
tion, which involves B cell–derived LT 1 2, and B cell1658 B Cell–derived LT 1 2 Promotes Spleen T Zone Development
promotion of T cell accumulation in the spleen, which
does not. We suggest that B cells provide signals, other
than LT 1 2, that allow the spleen to accommodate the
adult number of T cells. In this regard it is important to
note that B cells have been shown to provide signals neces-
sary for full development of Peyer’s patches (59, 60), and at
least some of these signals are suggested to be independent
of LT 1 2 (59).
Our findings establish an important role for B cells in
controlling spleen T zone development and provide a pos-
sible additional mechanism for how B cell deficiency may
cause defects in immunity unrelated to a lack of antibody
production. Such defects include reduced T cell responses
to  Salmonella typhimurium (61), Bordatella pertussis (62),
Chlamydia trachomatis (63), Francisella tulaensis (64), Plasmo-
dium chabaudi (65), and Leishmania major (66). B cells are
also required for development of auotreactive T cells in
MRL-lpr mice (33) and they facilitate T cell–mediated de-
struction of pancreatic  -cells in NOD mice (67). While B
cell antigen-presenting function may be a critical parameter
in these diseases, we propose that some of the defects of B
cell deficiency may reflect the role of B cells in promoting
CCL21 expression, T zone stromal cell development and
DC maturation or accumulation in spleen, in other B cell
rich organs, and in B cell-rich inflammatory lesions. Fu-
tures studies need to investigate the contributions of these
parameters to disease susceptibility in B cell–deficient hu-
mans, and to human inflammatory diseases involving B
cells (68, 69).
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